Marché du collagène médical – Tendances et analyse de la croissance | Année de prévision 2031

  • Report Code : TIPRE00012952
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 172
Buy Now

Le marché du collagène médical devrait atteindre 957,4 millions de dollars US d'ici 2028, contre 593,7 millions de dollars US en 2020 ; on estime qu'il croîtra à un TCAC de 6,2 % de 2021 à 2028.



Le collagène est la protéine la plus abondante dans le corps humain. Il survient principalement dans les tissus fibreux tels que les ligaments, la peau, les tendons, la cornée, les vaisseaux sanguins, les os, les cartilages et le disque intervertébral. Le collagène médical est un matériau biocompatible à faible immunogénicité. Le collagène a de bonnes propriétés hémostatiques et facilite la cicatrisation des plaies. Il est utilisé dans les cultures cellulaires car il favorise la prolifération cellulaire dans les structures en treillis et le domaine de liaison cellulaire. Le collagène médical est largement utilisé dans des applications telles que la cicatrisation des plaies, l'ingénierie tissulaire, les chirurgies reconstructives, les greffes osseuses et les chirurgies esthétiques. La croissance du marché du collagène médical est attribuée à des facteurs tels que l'augmentation des applications du collagène dans l'industrie médicale et l'augmentation des approbations de la FDA et des lancements de produits. Cependant, les rappels de produits entravent la croissance du marché. Couverture du rapport

Régions lucratives pour le marché du collagène médical

Aperçu du marché

Applications croissantes du collagène dans l'industrie médicale

Le collagène est la protéine présente dans les tissus conjonctifs du corps. C'est la protéine la plus abondante trouvée chez les mammifères, qui représente environ 25 à 35 % de la teneur en protéines du corps entier. Comme le collagène est faiblement antigénique et biodégradable, il a une excellente biocompatibilité. Ainsi, ce qui en fait une ressource principale dans les applications médicales.



La matrice extracellulaire cardiaque (ECM) est constituée de collagène fibrillaire qui fournit un moyen de transmission de force, préserve l'intégrité du myocarde et soutient la géométrie des myocytes. Plusieurs études ont prouvé que la consommation de suppléments de collagène aide à réduire le risque de maladies cardiaques.



Le collagène est l'un des constituants clés des formulations cosmétiques car il possède des propriétés hydratantes, régénérantes et filmogènes. Le collagène a une excellente capacité à lier l'eau qui aide à maintenir une bonne teneur en eau dans la peau tout au long de la journée, ce qui rend la peau hydratée et adoucie. De plus, les charges de collagène sont largement utilisées en médecine esthétique. L'injection sous-cutanée de collagène soluble améliore la qualité et la densité de la peau, réparant ainsi ses défauts dermatologiques.



Les biomatériaux à base de collagène ont un large éventail d'applications in vivo et in vitro. Le collagène a été largement utilisé pour développer des substituts de greffe osseuse synthétique de la colonne vertébrale, des extrémités et des dents. De plus, des échafaudages de collagène sont développés pour imiter et régénérer les tissus natifs et sont rapidement adoptés pour la réparation du cartilage.



Le collagène est naturellement impliqué dans le processus de cicatrisation des plaies et l'utilisation de pansements à base de collagène offre plusieurs avantages pour la fermeture des plaies aiguës et chroniques. De plus, les pansements au collagène peuvent contrôler l'humidité de la plaie, en absorbant ou en fournissant de l'humidité. Ainsi, le collagène est largement utilisé dans les pansements, les particules et les échafaudages fluides pour traiter les plaies aiguës et chroniques.



Cette large gamme d'applications du collagène dans l'industrie médicale favorise la croissance du marché.



Insights basés sur les produitsLe marché du collagène médical, par source, est segmenté en bovin, porcin et autres. Le segment bovin détenait la plus grande part du marché en 2020, et il devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Marché du collagène médical, par source - 2020 et 2028

Insights basés sur les produits



Sur la base des produits, le marché du collagène médical est segmenté en gélatine, collagène hydrolysé, collagène natif et autres. Le segment de la gélatine détenait la plus grande part de marché en 2020 et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Insights basés sur les applications



Sur la base des applications, le médical Le marché du collagène est segmenté en hémostatiques, greffes vasculaires, échafaudages tissulaires, réparation du cartilage, soins des plaies, greffes osseuses, diagnostics et autres. Le segment des soins des plaies détenait la plus grande part de marché en 2020, et le segment des greffes osseuses devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.



Insights stratégiques



Lancements de produits et les approbations sont les stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits. La collaboration est l'une des principales stratégies adoptées par les acteurs du marché du collagène médical pour élargir la clientèle dans le monde entier, ce qui, à son tour, leur permet de conserver leur marque à l'échelle mondiale.



Marché du collagène médical - par source


  • Bovin

  • Porc

  • Autres

Marché du collagène médical - par produit



  • Gélatine

  • Collagène hydrolysé

  • Collagène natif

  • Autres

Marché du collagène médical - par application



< ul>
  • Soins des plaies

  • Greffes osseuses

  • Échafaudages tissulaires

  • Réparation du cartilage

  • Hémostats

  • Diagnostics

  • Greffes vasculaires

  • Autre

  • Marché du collagène médical - par géographie




    • Amérique du Nord
        < li>États-Unis
      • Canada

      • Mexique


    • Europe

      • France

      • Allemagne

      • Italie

      • Royaume-Uni

      • Espagne

      • Reste de l'Europe


    • Asie Pacifique (APAC)

      • Chine

      • Inde

      • Corée du Sud

      • Japon

      • Australie
      • Reste de l'Asie-Pacifique


    • Moyen-Orient et Afrique (MEA)

      • Afrique du Sud

      • Arabie saoudite
      • EAU

      • Reste du Moyen-Orient et Afrique


    • Amérique du Sud et centrale

      • Brésil

      • Argentine

      • Reste de l'Amérique du Sud et centrale


    Profils des entreprises




    • DSM
    • Integra Lifesciences Corporation

    • Collagen Matrix Inc.

    • Encoll

    • Collagen Solutions Plc

    • Innocoll

    • Symatese

    • Gelita AG

    • Collplant Biotechnologies Ltd

    • Croda International PLC.

    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What are the driving factors for the medical collagen market across the globe?

    The global medical collagen market growth is mainly attributed to factors such the rising applications of collagen in medical industry and growing FDA approvals and product launches fuel the growth of the market. However, product recalls is the major factor hindering the market growth.

    Who are the major players in the medical collagen market?

    The medical collagen market majorly consists of the players such as DSM, Integra Lifesciences Corporation, Collagen Matrix, Inc., Encoll, Collagen Solutions Plc, Innocoll, Symatese, Gelita Ag, Collplant Biotechnologies Ltd, and Croda Interntional PLC. among others.

    What is medical collagen?

    Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry. The exponential increase in number of regenerative surgeries performed on patients to treat certain forms of skin cancers, burn injuries, birth defects, and congenital diseases is primarily expected to drive the demand for medical collagen.

    The List of Companies - Medical Collagen Market

    1. DSM
    2. INTEGRA LIFESCIENCES CORPORATION
    3. COLLAGEN MATRIX, INC.
    4. ENCOLL
    5. COLLAGEN SOLUTIONS PLC
    6. INNOCOLL
    7. SYMATESE
    8. GELITA AG
    9. COLLPLANT BIOTECHNOLOGIES LTD
    10. CRODA INTERNTIONAL PLC

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports